Evidence map›Paper›PMID 35284082›Full record

ArticleCanadian journal of kidney health and disease2022

Development and Feasibility of a Multidisciplinary Approach to AKI Survivorship in Care Transitions: Research Letter.

Erin F Barreto, Heather P May, Diana J Schreier, Laurie A Meade, Brenda K Anderson, Megan E Rensing, Kari L Ruud, Andrea G Kattah, Andrew D Rule, Rozalina G McCoy and 4 more

Open access · goldAbstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Acute Kidney Injury in Care Transitions (ACT): A Randomized Controlled Feasibility Trial.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Erin F BarretoDepartment of Pharmacy, Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0002-0996-1487
Heather P MayDepartment of Pharmacy, Mayo Clinic, Rochester, MN, USA.
Diana J SchreierDepartment of Pharmacy, Mayo Clinic, Rochester, MN, USA.
Laurie A MeadeAnesthesia Clinical Research Unit, Mayo Clinic, Rochester, MN, USA.
Brenda K AndersonAnesthesia Clinical Research Unit, Mayo Clinic, Rochester, MN, USA.
Megan E RensingStrategy Department, Mayo Clinic, Rochester, MN, USA.
Kari L RuudStrategy Department, Mayo Clinic, Rochester, MN, USA.
Andrea G KattahDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0001-7228-9876
Andrew D RuleDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Rozalina G McCoyRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
Dawn M FinnieRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
Joseph R HergesDepartment of Pharmacy, Mayo Clinic, Rochester, MN, USA.
Kianoush B KashaniDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
ACT Study Group
Mayo Clinic in Arizona · USMayo Clinic in Florida · USMayo Clinic · US

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
Beta-lactam individualization for critically ill patientsK23AI143882 · NIAID · MAYO CLINIC ROCHESTER · PI BARRETO, ERIN FRAZEE · 2020 to 2024
$986k
Predicting the Risk of Severe Hypoglycemic and Hyperglycemic Events in Adults with DiabetesK23DK114497 · NIDDK · MAYO CLINIC ROCHESTER · PI MCCOY, ROZALINA GRUBINA · 2017 to 2021
$846k
Enhanced kidney follow-up for AKI survivors in Care Transitions (the ACT Study)R03HS028060 · AHRQ · MAYO CLINIC ROCHESTER · PI BARRETO, ERIN FRAZEE · 2021 to 2022
$100k
AHRQ HHS R03 HS028060NCATS NIH HHS UL1 TR002377NIAID NIH HHS K23 AI143882NIDDK NIH HHS K23 DK114497
6 · The paper itself

Abstract

Background: Acute kidney injury (AKI) survivors are at heightened risk for poor short- and long-term health outcomes. Even among those who recover after an AKI episode, the risk for chronic kidney disease is 4- to 6-fold higher than in patients without AKI, underscoring the importance of identifying methods to improve AKI survivorship. Objective: The purpose of this report was to describe the development and feasibility of a novel multidisciplinary approach to caring for AKI survivors at care transitions (ACT). Design: Observational process improvement initiative. Setting: Single academic medical center in the United States. Patients: The studied population was adults with stage 3 AKI not discharging on dialysis who were established with a primary care provider (PCP) at our institution. Methods: An electronic health record tool was developed prior to implementation to identify AKI survivors. The ACT program encompassed engaging patients in the hospital, delivering education by nephrology-trained nurses before discharge, completing recommended laboratory testing after discharge, and conducting structured kidney-focused follow-up with a pharmacist and a PCP within 7 to 14 days after discharge. Patients could be referred for nephrology evaluation at the discretion of the PCP. Results: Preliminary data demonstrated that most AKI survivors of interest could be identified, educated, and followed up with this model. This strategy appeared feasible, scalable, and maximized the unique expertise of each member of the multidisciplinary team. Limitations: Small sample size, future assessment of process, clinical, and patient-reported outcomes needed. Conclusions: The multidisciplinary ACT workflow supported by clinical decision support was feasible and addressed gaps in existing care transition models. Team-based care delivery in primary care appears to be a mechanism to extend the capacity for kidney health monitoring for AKI survivors.

Indexed as

acute kidney injurycare transitionskidney diseasemultidisciplinary careoutcomesprimary carequality improvementteam-based care

Identifiers

PMID35284082
PMCPMC8905052
OpenAlexW4225919713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.